Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning
Abstract
Nitric oxide (NO) has been reported to play an important role in the late phase of ischemic preconditioning (PC) in the rabbit heart. However, the role of NO in the early phase of ischemic PC ("classical PC") is controversial. Accordingly, the present study was designed to determine whether NO contributes to the cardioprotective effect of classical PC in rabbits. Isolated hearts experienced 30 min of regional ischemia followed by 120 min of reperfusion. Infarct size was measured with triphenyltetrazolium chloride. In control hearts infarction was 30.2+/-3.3% of the risk zone. PC with 5 min of global ischemia and 10 min of reperfusion reduced infarct size to 10.2+/-2.4% (P<0.05). Perfusion with 2 microm S-nitroso-N-acetylpenicillamine (SNAP), a NO donor, in lieu of ischemia mimicked PC (4.4+/-1.9% infarction, P<0.01 v control). To determine whether this protection was dependent on either protein kinase C (PKC) as has previously been demonstrated for classical PC or free radicals known to be produced during exogenous NO administration, chelerythrine (5 microm), a PKC inhibitor, or N-(2-mercaptopropionyl)-glycine (300 microm), a free radical scavenger, was administered with or shortly after SNAP. Neither drug had any independent effect on infarct size, and each blocked SNAP's cardioprotection (31.0+/-5.1 and 25.7+/-5.2% infarction, resp.). N(omega)-nitro- L -arginine methyl ester (L -NAME, 100 microm), a NO synthase inhibitor, failed to block the cardioprotection from the above ischemic PC protocol (9.5+/-2.8% infarction, P<0.05 v control). L -NAME alone had no effect on infarct size (30.6+/-2.7%). These results suggest that the beneficial effect of exogenous NO production during SNAP pretreatment is mediated by a protein kinase C-dependent pathway via MPG-sensitive oxidants. However, we were unable to show any contribution of endogenous NO to classical PC's protection in isolated rabbit hearts.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NOS ability to generate NO during ischemia is compromised because of the requirement for oxygen, BH4, and other co-factors that may be limiting during tissue ischemia.
“Although NO is known to protect tissues from ischemic injury, the ability of nitric oxide synthases to generate NO during ischemia is compromised because of the requirement for oxygen, BH4, and other co-factors which may be limiting during tissue ischemia [29–31].”
From Inorganic nitrite therapy: historical perspective and future directions (2011) · cites this paper as [29]
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199 · see citing works
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,420 · see citing works
Guide for the care and use of laboratory animals
(1997) · Choice Reviews Online · doi:10.5860/choice.34-3310 · Cited by 2,930 · see citing works
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
Rees, D. D., Palmer, R. M. J., Schulz, R., Hodson, H. F., & Moncada, S. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14151.x · Cited by 1,856 · see citing works
Bolli, R., Jeroudi, M. O., Patel, B. S., Aruoma, O. I., Halliwell, B. B., Lai, E. K., & McCay, P. B. (1989) · Circulation Research · doi:10.1161/01.res.65.3.607 · Cited by 579 · see citing works
Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit Hearts
Goto, M., Liu, Y., Yang, X., Ardell, J. L., Cohen, M. V., & Downey, J. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.611 · Cited by 529 · see citing works
Self-citationBuxton, I. L. O., Cheek, D. J., Eckman, D. M., Westfall, D. P., Sanders, K. M., & Keef, K. D. (1993) · Circulation Research · doi:10.1161/01.res.72.2.387 · Cited by 508 · see citing works
Baines, C. P., Goto, M., & Downey, J. M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0265 · Cited by 484 · see citing works
Self-citationGeneration of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts
Yasmin, W. M. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00254-4 · Cited by 343 · see citing works
Nitric Oxide in the Vasculature: Physiology and Pathophysiology
Moncada, S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51989.x · Cited by 340 · see citing works
Oxygen Radicals Can Induce Preconditioning in Rabbit Hearts
Tritto, I., D’Andrea, D., Eramo, N., Scognamiglio, A., De Simone, C., Violante, A., Esposito, A., Chiariello, M., & Ambrosio, G. (1997) · Circulation Research · doi:10.1161/01.res.80.5.743 · Cited by 288 · see citing works
Lefer, D. J., Nakanishi, K., Johnston, W. E., & Vinten‐Johansen, J. (1993) · Circulation · doi:10.1161/01.cir.88.5.2337 · Cited by 271 · see citing works
Baxter, G. F., Marber, M. S., Patel, V. C., & Yellon, D. M. (1994) · Circulation · doi:10.1161/01.cir.90.6.2993 · Cited by 271 · see citing works
The nitric oxide hypothesis of late preconditioning
Bolli, R., Dawn, B., Tang, X.-L., Qiu, Y., Ping, P., Xuan, Y.-T., Jones, W. K., Takano, H., Guo, Y., & Zhang, J. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050101 · Cited by 270 · see citing works
Jones, S. P., Girod, W. G., Palazzo, A. J., Granger, D. N., Grisham, M. B., Jourd’heuil, D., Huang, P. L., & Lefer, D. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.5.h1567 · Cited by 265 · see citing works
Tsuchida, A., Liu, Y., Liu, G. S., Cohen, M. V., & Downey, J. M. (1994) · Circulation Research · doi:10.1161/01.res.75.3.576 · Cited by 258 · see citing works
Self-citationIsoform-Selective Activation of Protein Kinase C by Nitric Oxide in the Heart of Conscious Rabbits
Ping, P., Takano, H., Zhang, J., Tang, X., Qiu, Y., Li, R. C. X., Banerjee, S., Dawn, B., Balafonova, Z., & Bolli, R. (1999) · Circulation Research · doi:10.1161/01.res.84.5.587 · Cited by 257 · see citing works
Preconditioning of the ischaemic myocardium; involvement of the l ‐arginine nitric oxide pathway
Végh, Á., Szekeres, L., & Parratt, J. R. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14501.x · Cited by 235 · see citing works
Takano, H., Tang, X., Qiu, Y., Guo, Y., French, B. A., & Bolli, R. (1998) · Circulation Research · doi:10.1161/01.res.83.1.73 · Cited by 210 · see citing works
Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size
Nakanishi, K., Vinten-Johansen, J., Lefer, D. J., Zhao, Z., Fowler, W. C., McGee, D. S., & Johnston, W. E. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.6.h1650 · Cited by 181 · see citing works
Schulz, R., & Wambolt, R. B. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00064-x · Cited by 175 · see citing works
Baxter, G. F., Goma, F. M., & Yellon, D. M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15866.x · Cited by 161 · see citing works
Inhibition of Nitric Oxide Limits Infarct Size in the in Situ Rabbit Heart
Patel, V. C., Yellon, D. M., Singh, K. J., Neild, G. H., & Woolfson, R. G. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1809 · Cited by 158 · see citing works
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits
Qiu, Y., Rizvi, A., Tang, X., Manchikalapudi, S., Takano, H., Jadoon, A. K., Wu, W., & Bolli, R. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.6.h2931 · Cited by 155 · see citing works
Inhibition of Nitric Oxide Synthesis Reduces Infarct Size by an Adenosine-Dependent Mechanism
Woolfson, R. G., Patel, V. C., Neild, G. H., & Yellon, D. M. (1995) · Circulation · doi:10.1161/01.cir.91.5.1545 · Cited by 152 · see citing works
Signal Transduction in Ischemic Preconditioning:
Baines, C. P., Cohen, M. V., & Downey, J. M. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00251.x · Cited by 152 · see citing works
Self-citationYao, Z., & Gross, G. J. (1993) · Circulation Research · doi:10.1161/01.res.73.6.1193 · Cited by 135 · see citing works
Csonka, C., Szilvássy, Z., Fülöp, F., Páli, T., Blasig, I. E., Tósaki, Á., Schulz, R., & Ferdinándy, P. (1999) · Circulation · doi:10.1161/01.cir.100.22.2260 · Cited by 135 · see citing works
Depré, C., Vanoverschelde, J., Goudemant, J., Mottet, I., & Hue, L. (1995) · Circulation · doi:10.1161/01.cir.92.7.1911 · Cited by 134 · see citing works
Ferdinandy, P., Szilvássy, Z., Horváth, L. I., et al. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0557 · Cited by 129 · see citing works
Activation of nitric oxide synthase by ischaemia in the perfused heart
Depre, C. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00176-9 · Cited by 106 · see citing works
Ferdinándy, P., Csont, T., Csonka, C., et al. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005062 · Cited by 98 · see citing works
NASEEM, S., Kontos, M. C., RAO, P., Jesse, R., HESS, M., & Kukreja, R. C. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80038-7 · Cited by 98 · see citing works
Flögel, U., Decking, U. K. M., Gödecke, A., & Schrader, J. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0921 · Cited by 96 · see citing works
Wang, P. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0054 · Cited by 95 · see citing works
Mizumura, T., Nithipatikom, K., & Gross, G. J. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(96)88523-3 · Cited by 90 · see citing works
Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit
Williams, M. W., Taft, C. S., Ramnauth, S., Zhao, Z., & Vinten-Johansen, J. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00011-9 · Cited by 80 · see citing works
Weselcouch, E. O., Baird, A. J., Sleph, P. G., & Grover, G. J. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.1.h242 · Cited by 79 · see citing works
No Involvement of Endogenous Nitric Oxide In Classical Ischemic Preconditioning in Swine
Post, H., Schulz, R., Behrends, M., Gres, P., Umschlag, C., & Heusch, G. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1117 · Cited by 76 · see citing works
Self-citationNitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits.
Hoshida, S., Yamashita, N., Igarashi, J., Nishida, M., Hori, M., Kamada, T., Kuzuya, T., & Tada, M. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10512-0 · Cited by 66 · see citing works
Végh, Á., Papp, J. G., Szekeres, L., et al. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13384.x · Cited by 66 · see citing works
Dikalov, S., Khramtsov, V. V., & Zimmer, G. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0067 · Cited by 63 · see citing works
Schulz, R. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(95)00064-x · Cited by 61 · see citing works
Bugge, E., & Ytrehus, K. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0226 · Cited by 51 · see citing works
Lu, H. K., Remeysena, P., & Clerck, F. D. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199504000-00003 · Cited by 50 · see citing works
Mizumura, T. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(96)88523-3 · Cited by 39 · see citing works
Delayed myocardial protection following ischaemic preconditioning
Baxter, G. F., & Yellon, D. M. (1996) · Basic Research in Cardiology · doi:10.1007/bf00788865 · Cited by 20 · see citing works
Nitric oxide–generating β-adrenergic blocker nipradilol preserves postischemic cardiac function
Horimoto, H., Saltman, A. E., Gaudette, G. R., et al. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00809-7 · Cited by 20 · see citing works
Yang, B., & Mehta, J. L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00378-0 · Cited by 17 · see citing works
Protective effect of preconditioning on coronary occlusion induced arrhythmia involve prostaglandins
Komori, S., Sano, S., Ijiri, H., et al. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)90825-k · Cited by 15 · see citing works
Rajkovic, I. A., & Williams, R. T. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90177-1 · Cited by 15 · see citing works
Ischaemic preconditioning is not prevented by inhibition of endothelium-derived nitric oxide
Patel, V. C., Woolfson, R. G., Singh, K. J., et al. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)90480-n · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062 · see citing works
“Isolated rabbit hearts continued to be protected by ischemic preconditioning in the presence of L-NAME, strongly arguing against such a trigger role (247).”
BackgroundSelf-citationMolecular Basis of Cardioprotection
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811 · see citing works
“but endogenous NO seems to be no requisite for IPC in its acute form.(59,60) In contrast, endogenous NO—generated from”
BackgroundSelf-citationBolli, R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1462 · Cited by 597 · see citing works
Shiva, S., Sack, M. N., Greer, J. J., Duranski, M., Ringwood, L. A., Burwell, L., Wang, X., MacArthur, P. H., Shoja, A., Raghavachari, N., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070198 · Cited by 555 · see citing works
“Although NO is known to protect tissues from I/R injury, its therapeutic window is limited in terms of dose, source, and duration of exposure ( 19 – 23 ).”
BackgroundNitric oxide in myocardial ischemia/reperfusion injury
Schulz, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.019 · Cited by 462 · see citing works
Ferdinándy, P., & Schulz, R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705080 · Cited by 439 · see citing works
“However, enhancement of exogenous NO levels by pretreatment with a NO donor induced preconditioning via an antioxidant pathway (Nakano et al., 2000).”
BackgroundThe ubiquitous role of nitric oxide in cardioprotection
Jones, S. P., & Bolli, R. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.09.011 · Cited by 434 · see citing works
Sanada, S., Komuro, I., & Kitakaze, M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00553.2011 · Cited by 383 · see citing works
Signal transduction of ischemic preconditioning
Schulz, R. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00384-4 · Cited by 327 · see citing works
Signaling pathways in ischemic preconditioning
Downey, J. M., Davis, A., & Cohen, M. V. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9025-2 · Cited by 321 · see citing works
“We found that while NO is an important signaling element for IPC in the in vivo heart model [32], it is not in isolated hearts [33].”
BackgroundSelf-citationOldenburg, O., Qin, Q., Krieg, T., Yang, X., Philipp, S., Critz, S. D., Cohen, M. V., & Downey, J. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00360.2003 · Cited by 264 · see citing works
Self-citationROS and NO trigger early preconditioning: relationship to mitochondrial K<sub>ATP</sub> channel
Lebuffe, G., Schumacker, P. T., Shao, Z.-H., Anderson, T., Iwase, H., & Vanden Hoek, T. L. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00706.2002 · Cited by 227 · see citing works
“mitoKATP channel activation (6, 31) and NO (27) have each been suggested to trigger preconditioning through a free radical-mediated mech-”
BackgroundResultProtein <i>S</i> -Nitrosylation and Cardioprotection
Sun, J., & Murphy, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.209452 · Cited by 205 · see citing works
Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning
Pagliaro, P., Mancardi, D., Rastaldo, R., Penna, C. R. R., Gattullo, D., Miranda, K. M., Feelisch, M., Wink, D. A., Kass, D. A., & Paolocci, N. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01179-6 · Cited by 199 · see citing works
“through a free radical-mediated process not shared by endogenous NO [18].”
BackgroundYamamoto, T., & Bing, R. J. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22525.x · Cited by 193 · see citing works
Khan, S. A., Salloum, F. N., Das, A., Xi, L., Vetrovec, G. W., & Kukreja, R. C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.04.014 · Cited by 189 · see citing works
Burley, D. S., Ferdinandy, P., & Baxter, G. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707409 · Cited by 165 · see citing works
“SNAP and diethylenetriamine-nitric oxide (DETA-NO), or the NO precursor/NOS substrate L-arginine given before ischaemia, have generally found these compounds to limit infarct size and improve post-ischaemic functional recovery, mimicking classical preconditioning (Horimoto et al., 2000; Nakano et al., 2000; Suematsu e…”
BackgroundMethodNakano, A., Cohen, M. V., & Downey, J. M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00058-9 · Cited by 164 · see citing works
Self-citationRecent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis
Schulz, R., Rassaf, T., Massion, P. B., Kelm, M., & Balligand, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.005 · Cited by 146 · see citing works
Ischemic preconditioning: nearly two decades of research. A comprehensive review
Eisen, A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00238-7 · Cited by 144 · see citing works
The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts
Okada, H., Kurita, T., Mochizuki, T., et al. (2007) · Resuscitation · doi:10.1016/j.resuscitation.2007.01.032 · Cited by 143 · see citing works
Nitroglycerin and Delayed Preconditioning in Humans
Heusch, G. (2001) · Circulation · doi:10.1161/01.cir.103.24.2876 · Cited by 134 · see citing works
Self-citationRole of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury
Singhal, A. K., Symons, J. D., Boudina, S., Jaishy, B. P., & Shiu, Y.-T. E. (2010) · Vascular Disease Prevention · doi:10.2174/1874120701007010001 · Cited by 133 · see citing works
Nadtochiy, S. M., Baker, P. R. S., Freeman, B. A., & Brookes, P. S. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn323 · Cited by 131 · see citing works
“The overall role of NOS in IPC is somewhat controversial,(42) since in vivo studies suggest NOS is essential for IPC,(43) whereas in vitro studies have found that L-NAME does not block IPC.(44,45) The mechanism by which nitro fatty acids are liberated from membranes may involve PLA2, which is known to liberate linolea…”
BackgroundInfluentialPromising effects of ischemic preconditioning in renal transplantation
Torrás, J., Herrero, I., Lloberas, N., Riera, M., Cruzado, J. M., & Grinyó, J. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00360.x · Cited by 131 · see citing works
“22 , while exogenous NO administration may also mimic ischemic preconditionin”
BackgroundCOHEN, M., YANG, X., & Downey, J. M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.021 · Cited by 128 · see citing works
“The NO donor S-nitroso-N-acetylpenicillamine (SNAP) given prior to ischemia mimicked IPC and protected the hearts [8].”
BackgroundResultInfluentialSelf-citationPathophysiology of Myocardial Infarction
Skyschally, A., Schulz, R., & Heusch, G. (2008) · Herz · doi:10.1007/s00059-008-3101-9 · Cited by 116 · see citing works
“However, exogenous nitric oxide triggers preconditioning [111].”
Self-citationInorganic nitrite therapy: historical perspective and future directions
Kevil, C. G., Kolluru, G. K., Pattillo, C. B., & Giordano, T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.042 · Cited by 113 · see citing works
Xu, Z., Ji, X., & Boysen, P. G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00882.2003 · Cited by 110 · see citing works
Steensrud, T., Li, J., Dai, X., Manlhiot, C., Kharbanda, R. K., Tropak, M. B., & Redington, A. N. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00396.2010 · Cited by 109 · see citing works
Cohen, M. V., & Downey, J. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12903 · Cited by 108 · see citing works
“In a study in in vitro rabbit hearts published in 2000, we noted that N-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor, had no effect on the dramatic protection induced by IPC, whereas the NO donor S-nitroso-Nacetylpenicillamine administered before the index ischaemia in lieu of the repeated brief 5 min coron…”
BackgroundMethodSelf-citationNovalija, E., Varadarajan, S. G., Camara, A. K. S., An, J., Chen, Q., Riess, M. L., Hogg, N., & Stowe, D. F. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01056.2001 · Cited by 105 · see citing works
“The seemingly paradoxical role of ROS and reactive nitrogen species (RNS) in triggering or mediating IPC has gained increasing importance (23, 33, 37).”
BackgroundHill, M., Takano, H., Tang, X., Kodani, E., Shirk, G., & Bolli, R. (2001) · Circulation · doi:10.1161/hc3201.092218 · Cited by 103 · see citing works
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Ye, Y., Perez-Polo, J. R., Aguilar, D. A., & Birnbaum, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0216-6 · Cited by 100 · see citing works
“However, it seems that role of endogenous nitric oxide in mediating classical early phase ischemic preconditioning is less clear, as it has been reported that L-NAME does not block classic ischemic preconditioning in pigs [139] and rabbits [117].”
Ischemic Preconditioning: From Molecular Mechanisms to Therapeutic Opportunities
Otani, H. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1679 · Cited by 101 · see citing works
Hentia, C., Rizzato, A., Camporesi, E., Yang, Z., Muntean, D. M., Săndesc, D., & Bosco, G. (2018) · Brain and Behavior · doi:10.1002/brb3.959 · Cited by 95 · see citing works
Ischemic preconditioning in solid organ transplantation: from experimental to clinics
Ambrós, J. T., Herrero, I., Gulías, Ò., et al. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00418.x · Cited by 94 · see citing works
“OFR [66,72–75,85,92] Nitric oxide donors [62,66,69,92,99]”
Görbe, A., Giricz, Z., Szunyog, A., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0097-0 · Cited by 92 · see citing works
“Although the role of endogenous NO in classic ischemic preconditioning mediated cardioprotection was once refuted [ 32 ], many studies have shown that NO plays a significant role in triggering the preconditioned state, and its importance in the signal transduction pathways of other forms of cardioprotection such as is…”
BackgroundSun, J., Nguyen, T. T. M., Aponte, A. M., Menazza, S., Kohr, M. J., Roth, D. M., Patel, H. H., Murphy, E., & Steenbergen, C. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv044 · Cited by 91 · see citing works
Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model
Babaei, S. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00287-0 · Cited by 91 · see citing works
Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism
Qin, Q., Yang, X., Cui, L., Critz, S. D., Cohen, M. V., Browner, N. C., Lincoln, T., & Downey, J. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00954.2003 · Cited by 87 · see citing works
Self-citationPagliaro, P. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00593-9 · Cited by 86 · see citing works
Васильевна, Б. М., Davidson, S. M., Gourine, A. V., & Yellon, D. M. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0684-z · Cited by 83 · see citing works
“In terms of planning future clinical studies on the effect of RIC, it is important to keep in mind that exogenous NO [98] and nitroglycerin [35, 50, 148, 155] have been shown to be able to reduce infarct size, and may therefore, potentially interfere with RIC.”
BackgroundBell, R. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00394-7 · Cited by 82 · see citing works
Hausenloy, D. J. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319250004 · Cited by 81 · see citing works
“Whether the signalling molecule nitric oxide (NO) is a trigger for classical IPC was initially controversial [127-130].”
BackgroundIschemic preconditioning is not cardioprotective in senescent human myocardium
Bartling, B., Friedrich, I., Silber, R., et al. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00186-3 · Cited by 79 · see citing works
“Exogenous nitric oxide has been shown to trigger preconditioning through formation of reactive nitrogen species while endogenous nitric oxide seems not to be involved [22].”
BackgroundWolfrum, S., Grimm, M. F., Heidbreder, M., Dendorfer, A., Katus, H. A., Liao, J. K., & Richardt, G. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200303000-00017 · Cited by 77 · see citing works
Ambrosio, G., Pinto, M. D., Tritto, I., Agnelli, G., Bentivoglio, M., Zuchi, C., Anderson, F. A., Gore, J. M., López-Sendón, J., Wyman, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp457 · Cited by 75 · see citing works
“opening of KATP channels, 24– 27 and changes in myocardial redox status.(16,17,28,29) Because of their ease of use and favourable safety profile, nitrates are the mainstay therapy of stable coronary artery disease.”
BackgroundYang, C., Talukder, M. A. H., Varadharaj, S., Velayutham, M., & Zweier, J. L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs287 · Cited by 74 · see citing works
Bell, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00675-2 · Cited by 73 · see citing works
Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals
Dendorfer, A., Heidbreder, M., Hellwig-Bürgel, T., Jöhren, O., Qadri, F., & Dominiak, P. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.015 · Cited by 68 · see citing works
JANG, Y., WANG, H., Xi, J., et al. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.015 · Cited by 66 · see citing works
Infarct size limitation by nicorandil
Tsuchida, A., Miura, T., Tanno, M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02268-4 · Cited by 66 · see citing works
“(13) showed that anti-infarct tolerance of the myocar-”
BackgroundChiueh, C., Andoh, T., & Chock, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.034 · Cited by 67 · see citing works
Hu, Y., Lu, L., Tian, S., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.09.269 · Cited by 65 · see citing works
Cardiac NO signalling in the metabolic syndrome
Pecháňová, O., Varga, Z. V., Cebová, M., Giricz, Z., Pacher, P., & Ferdinándy, P. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12960 · Cited by 62 · see citing works
“Nevertheless, it seems that mild oxidative/nitrative stress induced by exogenous or endogenous NO is necessary to trigger both pre- and post-conditioning (Nakano et al., 2000; Csonka et al., 2001; Heusch, 2001; Kupai et al., 2009).”
BackgroundTNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits
Belosjorow, S., Bolle, I., Duschin, A., Heusch, G., & Schulz, R. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00374.2002 · Cited by 60 · see citing works
“For example, nitric oxide when applied exogenously mimicks the infarct size reduction of IP (15); however, blockade of endogenous nitric oxide does not abolish the protection of IP (15, 16).”
BackgroundSelf-citationOpportunities for Nitric Oxide in Potentiating Cancer Immunotherapy
Kim, J., & Thomas, S. N. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000500 · Cited by 60 · see citing works
“However, in several cells, exogenously delivered NO can act differently from endogenously generated NO (Gansauge et al., 1997; Nakano et al., 2000).”
BackgroundIschemic preconditioning: emerging evidence, controversy, and translational trials
Sanada, S., & Kitakaze, M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.12.002 · Cited by 58 · see citing works
Peart, J. N. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00259-1 · Cited by 56 · see citing works
Zhang, D., Chai, Y., Erickson, J. R., Brown, J. H., Bers, D. M., & Lin, Y. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264697 · Cited by 55 · see citing works
“It has also been shown that late and early preconditioning induced by NO donors is blocked by the ROS scavenger MPG, implying that ROS are involved in cardioprotection induced by (exogenous) NO (Takano et al. 1998; Nakano et al. 2000); in light of the present findings, protection by NO in the heart may involve ROS-dep…”
BackgroundKim, J., Sestito, L. F., Im, S., Kim, W. J., & Thomas, S. N. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908788 · Cited by 54 · see citing works
Philipp, S., Cui, L., Ludolph, B., Kelm, M., Schulz, R., Cohen, M. V., & Downey, J. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00472.2005 · Cited by 54 · see citing works
Self-citationWeerateerangkul, P., Chattipakorn, S. C., & Chattipakorn, N. (2011) · Medical Science Monitor · doi:10.12659/msm.881385 · Cited by 53 · see citing works
Yada, T., Shimokawa, H., Hiramatsu, O., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.053 · Cited by 52 · see citing works
Iwase, H., Robin, E., Guzy, R. D., Mungai, P. T., Hoek, T. L. V., Chandel, N. S., Levraut, J., & Schumacker, P. T. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.017 · Cited by 51 · see citing works
The role of NO in ischemia/reperfusion injury in isolated rat heart.
Andelová, E., Barteková, M., Pancza, D., Styk, J., & Ravíngerová, T. (2005) · PubMed · Cited by 49 · see citing works
Role of Cyclic Guanosine Monophosphate in Late Preconditioning in Conscious Rabbits
Kodani, E., Xuan, Y., Takano, H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000019408.67709.b5 · Cited by 47 · see citing works
Nicorandil: A drug with ongoing benefits and different mechanisms in various diseased conditions
Ahmed, L. (2019) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_298_19 · Cited by 46 · see citing works
Hypothermic preconditioning induces rapid tolerance to focal ischemic injury in the rat
Yunoki, M., Nishio, S., Ukita, N., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00056-6 · Cited by 44 · see citing works
Waldow, T., Witt, W., Weber, E., & Matschke, K. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.12.005 · Cited by 44 · see citing works
Pharmacology of mitochondrial permeability transition pore inhibitors
Naryzhnaya, N. V., Маслов, Л. Н., & Oeltgen, P. R. (2019) · Drug Development Research · doi:10.1002/ddr.21593 · Cited by 42 · see citing works
Mechanisms of acetylcholine- and bradykinin-induced preconditioning
Critz, S. D., Cohen, M. V., & Downey, J. M. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.02.007 · Cited by 41 · see citing works
Self-citationLevosimendan Modulates Programmed Forms of Cell Death Through KATP Channels and Nitric Oxide
Uberti, F., Caimmi, P. P., Molinari, C., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318204bb55 · Cited by 40 · see citing works
Is ischemic preconditioning of the kidney clinically relevant?
Kosieradzki, M., Ametani, M. S., Southard, J. H., et al. (2003) · Surgery · doi:10.1067/msy.2003.93 · Cited by 40 · see citing works
Desflurane-induced Preconditioning against Myocardial Infarction Is Mediated by Nitric Oxide
Smul, T. M., Lange, M., Redel, A., et al. (2006) · Anesthesiology · doi:10.1097/00000542-200610000-00018 · Cited by 37 · see citing works
Role of S-nitrosothiol transport in the cardioprotective effects of S-nitrosocysteine in rat hearts
Hogg, N., Broniowska, K. A., Novalija, J., Kettenhofen, N. J., & Novalija, E. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.06.016 · Cited by 33 · see citing works
Ruusalepp, A., Czibik, G., Flatebø, T., et al. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0644-5 · Cited by 34 · see citing works
Balance of Nitric Oxide and Reactive Oxygen Species in Myocardial Reperfusion Injury and Protection
Folino, A., Losano, G., & Rastaldo, R. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a50c45 · Cited by 32 · see citing works
Involvement of endogenous prostaglandins in ischemic preconditioning in pigs
Gres, P. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00505-3 · Cited by 33 · see citing works
Nitric Oxide in Cardiac Surgery: A Review Article
Олегович, К. Н., Duong, N., & Berra, L. M. (2023) · Biomedicines · doi:10.3390/biomedicines11041085 · Cited by 34 · see citing works
“Studies on ischemia-induced effects of the early PC phase demonstrated that the inhibition of endogenous NO synthesis by NO-synthase antagonists does not affect the protective effects of ischemic PC against cell death, post-ischemic dysfunction and arrhythmias [68,69].”
BackgroundHarada, N., Miura, T., Dairaku, Y., et al. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200407000-00005 · Cited by 32 · see citing works
“NO activates protein kinase C (PKC) isoforms such as - and - in the rat heart and confers ischemic tolerance.(7,8) Sato et al(9) showed a mechanistic link between PKC and mitochondrial K-ATP channels since phorbol ester potentiated their opening.”
BackgroundShi, L., Zhao, X., Zhong, K., et al. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128318 · Cited by 30 · see citing works
Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats
Fu, Y., Wang, Z., Chen, W. L., Moore, P. K., & Zhu, Y. Z. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00064.2007 · Cited by 28 · see citing works
“(28, 33, 43), although the exact targets or effectors of NO in PC”
BackgroundChiari, P. C., Bouvet, F., & Piriou, V. (2005) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2005.01.020 · Cited by 29 · see citing works
Nitrate tolerance does not increase production of peroxynitrite in the heart
Csont, T., Csonka, C., Ónody, A., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00817.2001 · Cited by 29 · see citing works
“Furthermore, nitroglycerin and other NO donors have been shown to be cardioprotective by inducing delayed (or late) preconditioning via a possible free radical-mediated trigger mechanism (2, 26, 37).”
BackgroundRole of nitric oxide and protein kinase C in ACh-induced cardioprotection
Liu, H., McPherson, B. C., Zhu, X., Costa, M. L. A. D., Jeevanandam, V., & Yao, Z. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h191 · Cited by 28 · see citing works
“Nitric oxide activated PKC and mediated cardioprotection in isolated rabbit hearts (6, 19).”
BackgroundGuo, Y., Li, Q., Wu, W., Tan, W. F., Zhu, X., Mu, J., & Bolli, R. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.01.003 · Cited by 28 · see citing works
“[23] concluded that eNOS is required for the mediation of early PC, whereas three other studies found NOS not to be necessary in rabbits [24,25] or pigs [26].”
ResultGe, Z., Ionova, I. A., Vladic, N., Pravdić, D., Hirata, N., Vasquez-Vivar, J. M., Pratt, P. F., Warltier, D. C., Pieper, G. M., & Kersten, J. R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr079 · Cited by 28 · see citing works
Muscari, C., Bonafè, F., Gamberini, C., et al. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.10.001 · Cited by 27 · see citing works
Strijdom, H., Genade, S., & Lochner, A. (2004) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000029027.50796.84 · Cited by 27 · see citing works
“[33] (isolated rabbit hearts) demonstrated that LNAME + IP treatment did not alter cardioprotection and it was suggested that endogenous production of NO during the IP protocol was insufficient and therefore ineffective to trigger protection.”
BackgroundMethodInfluentialPagliaro, P., Weber, N. C., Femminò, S., Alloatti, G., & Penna, C. R. R. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01061-1 · Cited by 26 · see citing works
“For instance, the administration of exogenous NO, such as S-nitroso-N-acetylpenicillamine, demonstrated a beneficial effect in reducing infarct size [123].”
Backgroundde Prati, A. C., Podesser, B. K., Faggian, G. G., Scarabelli, T. M., Mazzucco, A., Darra, E., Rungatscher, A., Hallström, S., & Suzuki, H. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0554 · Cited by 26 · see citing works
“Endogenous NOS-derived NO is not a trigger or mediator of the early phase of ischaemic PC against infarction either in rabbits (80) or pigs (81).”
BackgroundMartelli, A., Breschi, M. C., & Calderone, V. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315611 · Cited by 25 · see citing works
“Although, to date, the different experimental approaches on different animal species do not allow a consistent unitary theory about the exact role played by endogenous NO and the specific contributions of the different isoforms of NO synthase [37-38], there are clear and unequivocal evidences that the administration o…”
BackgroundRickover, O., Zinman, T., Kaplan, D., & Shainberg, A. (2007) · Cell Calcium · doi:10.1016/j.ceca.2007.06.003 · Cited by 25 · see citing works
Zhang, F., Oswald, T. M., Holt, J. J., et al. (2004) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000099713.64498.9e · Cited by 25 · see citing works
Asanuma, H., Nakai, K., Sanada, S., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.12.001 · Cited by 24 · see citing works
Ischemic Preconditioning: Triggering Role of Nitric Oxide-Derived Oxidants in Isolated Hearts
Novalija, E., Hogg, N., Kevin, L. G., Camara, A. K. S., & Stowe, D. F. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200311000-00003 · Cited by 24 · see citing works
Lü, X., Zhang, G., Yu, Y., Kimura, S., Nishiyama, A., Matsuyoshi, H., Shimizu, J., & Takaki, M. (2009) · The Journal of Physiological Sciences · doi:10.1007/s12576-009-0030-1 · Cited by 22 · see citing works
Imani, A., Faghihi, M., Sadr, S. S., et al. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.10.025 · Cited by 22 · see citing works
“In the isolated hearts treated with a NO synthase (NOS) inhibitor, no effect against early cardioprotection was seen [5].”
Method
- Authors
- Nakano, A., Liu, G. S., Heusch, G., Downey, J. M., & Cohen, M. V.
- Affiliations
- University of South Alabama (US)
- Stiftung Universitätsmedizin Essen (DE)
- Corresponding author
- Cohen, Michael V
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 32
- Issue
- 7
- Pages
- 1159-1167
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2038367443
- Semantic Scholar
- 2e56ce0aa902143915c04af510144ddd5622abf5
- Cited by
- 171
- References
- 51
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 4 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 10 · 2012: 6
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular and Cellular Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL20648, R01HL050688, HL50688, R01HL020648)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- ischemic preconditioning, nitric oxide, free radicals, protein kinase C, cardioprotection, myocardial infarct size, ischemia-reperfusion injury, S-nitroso-N-acetylpenicillamine, NADPH oxidase, chelerythrine, N-(2-mercaptopropionyl)glycine, L-NAME, nitric oxide synthase
- MeSH terms
- Animals, Antioxidants, Enzyme Inhibitors, Female, Free Radicals, Glycine, Heart, Hemodynamics, Male, Myocardial Infarction, Myocardium, Nitric Oxide, Penicillamine, Protein Kinase C, Rabbits, Sulfhydryl Compounds, Ischemic Preconditioning, Myocardial, NG-Nitroarginine Methyl Ester, Nitric Oxide Donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review